NIMH Study on Brain Function in Pediatric Bipolar Disorder
The NIMH is conducting a study to investigate severe mood dysregulation in children aged 7-17, focusing on symptoms and brain changes.
Asset / Drug
Drug and asset intelligence for NIMH with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.